Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPT
Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPT
Karsten Tange Veien, Erik Lerkevang Grove, Michael Mæng, Mia Ravn Jacobsen et al.
Citations
2 citations
Journal
American Heart Journal
Topics
Antiplatelet Therapy and Cardiovascular Diseases
Field-Weighted Citation Impact (FWCI)
2.78
article
Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPT
Karsten Tange Veien, Erik Lerkevang Grove, Michael Mæng, Mia Ravn Jacobsen, Mikkel Hougaard, Reza Jabbari, Thomas Engstrøm, Mette Charlot, Henning Kelbæk, Phillip Freeman, Rikke Sørensen
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
American Heart JournalVol. 285
Institutions
Aalborg University Hospital (DK), Odense University Hospital (DK), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Zealand University Hospital (DK)